A deal at the Department of Health (DH) to sell off the healthcare data provider it controversially bought almost four years ago has fallen through with private equity firm Palamon Capital Partners withdrawing from proceedings.
A deal at the Department of Health (DH) to sell off the healthcare data provider it controversially bought almost four years ago has fallen through with private equity firm Palamon Capital Partners withdrawing from proceedings.